In Vivo Knockout of the Vegfa Gene by Lentiviral Delivery of CRISPR/Cas9 in Mouse Retinal Pigment Epithelium Cells-Reference-Cited by-同舟云学术

In Vivo Knockout of the Vegfa Gene by Lentiviral Delivery of CRISPR/Cas9 in Mouse Retinal Pigment Epithelium Cells

Published:2017-12 Issue: Volume:9 Page:89-99
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Holmgaard Andreas,Askou Anne Louise,Benckendorff Josephine Natalia Esther,Thomsen Emil Aagaard,Cai Yujia,Bek Toke,Mikkelsen Jacob Giehm,Corydon Thomas J.

Funder

Faculty of Health Sciences

the Danish Council for Independent Research

Gene Therapy Initiative Aarhus

Lundbeck Foundation

the Danish Eye Foundation

Aase og Ejnar Danielsen’s Foundation

Knud and Edith Eriksen’s Foundation

Maskinfabrikant Jochum Jensen og hustru Mette Marie Jensen f. Poulsens Mindelegat

the Riisfort Foundation

Svend Helge Schrøder og hustru Ketty Lydia Larsen Schrøders

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference42 articles.

1. Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease;Trapani;Hum. Mol. Genet.,2015

2. A gene regulatory network controls the binary fate decision of rod and bipolar cells in the vertebrate retina;Wang;Dev. Cell,2014

3. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype;Yin;Nat. Biotechnol.,2014

4. In vivo editing of the human mutant rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina;Latella;Mol. Ther. Nucleic Acids,2016

5. CRISPR/Cas9-mediated genome editing as a therapeutic approach for Leber congenital amaurosis 10;Ruan;Mol. Ther.,2017

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the evolving CRISPR/Cas9 for precision oncology;Journal of Translational Medicine;2024-08-08

2. Multifunctional nano-in-micro delivery systems for targeted therapy in fundus neovascularization diseases;Journal of Nanobiotechnology;2024-06-20

3. Gene therapy for age-related macular degeneration: potential, feasibility, and pitfalls;Current Opinion in Ophthalmology;2024-03-04

4. CRISPR‐based gene therapy for wet age‐related macular degeneration in mouse model;Clinical and Translational Discovery;2024-02

5. Benefits and Caveats in the Use of Retinal Pigment Epithelium-Specific Cre Mice;International Journal of Molecular Sciences;2024-01-20